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Bioinformatic analysisIn this study, through linkage analysis of a four-generation Chinese family with multiple members afﬂicted
with DGI (type II), we identiﬁed a novel missense mutation in DSPP. The mutation was located in exon 2 at
the second nucleotide position of the last codon and resulted in a substitution of a proline with a leucine res-
idue (c.50C>T, p.P17L, g.50C>T). To assess the potential effects of this novel mutation, we utilized various
bioinformatics analysis programs. The results indicate that the mutation likely affects protein cleavage/
trafﬁcking. We also analyzed previously reported mutations of DSPP. In summary, our ﬁnding supports that
the genomic sequence that corresponds to the P17 residue of DSPP is a mutational hotspot and P17 may be
critical for the function of DSPP.
© 2012 Elsevier Inc. All rights reserved.1. Introduction
Dentin is the mineralized tissue constituting the body of a tooth,
serving as a protective covering for the pulp and as a support for over-
lying enamel and cementum [1]. Hereditary dentin defects are auto-
somal dominant disorders that occur in mineralized tissues and may
occur in combination with defects in other organs or tissues [2]. Gen-
erally, hereditary dentin defects have been classiﬁed by clinical and
radiographic information into two categories: dentinogenesis imper-
fecta (DGI-I: OMIM 166240; DGI-II: OMIM 125490; DGI-III: OMIM
125500) and dentin dysplasia (DD-I: OMIM 125400; DD-II: OMIM
125420) [3,4]. DGI-II is the most prevalent inherited defect, affecting
the dentin matrix with an estimated incidence between 1:6000 and
1:8000 [5,6]. The main diagnostic features of DGI-II are blue-gray or
amber-brown and opalescent teeth in both deciduous and permanent
dentitions. Radiographs show bulbous crowns, narrow roots, andand Molecular Biology, Xi'an
Rd, Xi'an, Shaanxi 710061, PR
oratory for the Genetics of De-
of Education), Shanghai Jiao
, PR China.
ajie.paper@gmail.com (J. Ma).
rights reserved.obliterated pulp chambers; and histologically, the dentinal tubules
are sparse and irregular [1,7,8].
To date, only one disease-causing gene, the dentin sialophospho-
protein (DSPP) gene (NM_014208), has been identiﬁed for the
above-mentioned disorders excepting for DGI-I [1,3,9–13]. DSPP is lo-
cated on human chromosome position 4q22.1 and is comprised of 5
exons spanning approximately 8350 bp. DSPP is synthesized as a sin-
gle protein by odontoblasts and is cleaved by BMP1 into two separate
proteins: dentin sialoprotein (DSP) and dentin phosphoprotein (DPP)
[14,15]. The DSP domain is towards the NH2 terminus (exons 1–4 and
the 5′ region of exon 5), and the DPP sequence is located towards the
COOH terminus (remainder of exon 5) [16]. In porcine teeth, Yama-
koshi et al. reported that DSPP consists of three dentin matrix pro-
teins, the two aforementioned proteins and dentin glycoprotein
(DGP), which is located at exon 5 between the DSP and DPP domains
(Supplementary Fig. 1A) [16–18]. Currently, 35 DSPP mutations have
been detected in various ethnic populations. It is notable that 14 mis-
sense or nonsense mutations are located within the DSP region
[3,5–7,9,11,12,19–26], and that 21 mutations located in the DPP re-
gion cause frameshift mutations [3,4,13,15,27,28].
In the current study, we describe a four-generation Chinese family
with DGI-II, and identiﬁed a novel missense DSPPmutation (c.50C>T,
p.P17L, g.50C>T) that is located within exon 2 at the second nucleo-
tide position of the last codon within DSPP. Our ﬁnding supports
that the genomic location that corresponds to the P17 residue is a
Fig. 1. Haplotype of the Chinese family affected by DGI-II. Open and blackened symbols
indicate unaffected and affected individuals respectively. Squares and circles symbolize
male and female. The proband, III-2, is indicated by an arrow. The haplotype was con-
ducted using ﬁve polymorphic microsatellite markers. Marker order was determined
from the Marshﬁeld map and UCSC Human Genome database (Feb, 2009). The dark
boxes symbolize haplotype cosegregating with affected individuals, suggesting linkage
of DSPP to DGI-II in this family.
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the function of DSPP [9].2. Results
In the Chinese family with DGI-II, the proband was a 46-year-old
female (Fig. 1: III-2). At the age of 10 years, her enamel layer was
lost through attrition in the absence of a history of periapical infec-
tions. Both her primary and permanent teeth were affected, her per-
manent teeth exhibited a shade of brown [26]. Similar clinical
features were detected in other affected family members [9]. Mean-
while, no high-frequency hearing loss or obvious skeletal abnormali-
ties were found in any of the affected individuals. The oralFig. 2. Clinical phenotype of DGI-II. A and C: Clinical photographs and radiographs from the p
from a patient (III-5), a man 44 years of age.radiographs of the proband and her affected brother (Fig. 1: III-5)
are shown in Fig. 2.
2.1. Linkage and haplotype analysis
We carried out linkage analysis using ﬁve markers that spanned
DSPP. A maximal LOD score of 1.17 was obtained for marker
D4S2929 and D4S1563 at theta=0.00, indicating potential linkage
(Supplementary Table 1). Actually, we have simulated the maximum
LOD score of the pedigree in the initial of this study, but themaximum
LOD score was no more than 1.50 (theta=0) for the modest family
size. Furthermore, when we removed the patients from this family,
the LOD score for D4S2929 decreased to 0.25 (theta=0). With haplo-
type analysis, a recombination event between D4S1452 and D4S2929
in individual III-5 was found to deﬁne the distal border of the disease
chromosome, suggesting DSPP, the known gene of DGI-II in the same
region is most responsible for the disease in this family (Fig. 1).
2.2. Mutation analysis
Mutation screening identiﬁed a novel, functional C>T transition
mutation, which is located within exon 2 at the second nucleotide po-
sition of the last codon within the DSPP gene, resulting in a substitu-
tion of a proline at position 17 with a leucine residue (c.50C>T,
p.P17L, g.50C>T). This alteration was conﬁrmed only in the affected
members of the family, and was not detected in any unaffected family
members (Fig. 3). Moreover, this nucleotide substitution was not
found in 160 healthy control individuals (320 alleles), demonstrating
that this alteration was not a polymorphic variant of DSPP. Further-
more, the genomic sequence corresponding to the P17 residue of
DSP is evolutionarily conserved in humans and several other mam-
malian species [5,9].
2.3. Bioinformatic analysis of the mutation effect
The available non-synonymous variants prediction program,
PolyPhen-2, was used to predict the structural and functional affects
that this mutation may have on DSPP, and the prediction for this al-
teration suggested Probably Damaging (score: 0.998). Moreover, a
total of nine mutations (p.Y6D, p.A15V, p.P17T, p.P17S, p.P17L,
p.V18F, p.V18D, p.Q45X, p.R68W) have been identiﬁed within DSP
from different studies [3,5,7,9,11,12,19–24] and no predicting results
outside of the Probably Damaging were found for eight of the muta-
tions. Since the mutation p.Q45X creates a stop codon in exon 3, the
PolyPhen-2 software was unable to analyze it (Table 1).roband (III-2), a woman 46 years of age. B and D: Clinical photographs and radiographs
Fig. 3. Identiﬁcation of a novel mutation, c.50C>T (p.P17L), in DSPP in a Chinese family
with DGI-II. DNA sequences were shown from a normal family member (above) and
the proband III-2 (below). The sequence of codon 17 where the mutation occurs is
marked. The C to T change in the proband results in the substitution of a proline resi-
due (CCA) by a leucine residue (CTA) in the DSP protein.
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protein showed that the most likely cleavage site was between pos.
15–16 and that the max cleavage site probability was 0.946. For the
substitution of p.P17L (c.50C>T), the max cleavage site probability
decreased to 0.695 at the same position. Furthermore, when the anal-
ysis was also performed for the other eight mutations identiﬁed by
previous studies [3,5,7,9,11,12,19–24], we found that three of the mu-
tations (p.Y6D, p.P17T, p.P17S) [3,9,11,19] decreased the max cleav-
age site probability, one mutation (p.A15V) [20] changed the most
likely cleavage site, and four mutations (p.V18F, p.V18D, p.Q45X,
p.R68W) [5,7,11,12,20–24] had almost no changes on the max cleav-
age site probability at pos. 15–16 (Table 1).
In the analysis of this mutation (c.50C>T) on the pre-mRNA splic-
ing, the result did not support it as a mutation that affected splicing.
There was no change in the prediction conﬁdence value
(0.98→0.98) based on the results from the Fruitﬂy Splice prediction,
and only a small change in the splice donor site prediction value
(0.904→0.775) based on the results from the SplicePort prediction.
In addition, similar results were found for the other 14 mutations
(c.16T>G, c.44C>T, c.49C>A, c.49C>T, c.52-25del23bp, c.52-3C>G,
c.52-3C>A, c.52G>T, c.53T>A, c.133C>T, c.135+1G>A, c.135+
1G>T, c.135+3A>G, c.202A>T) in the DSP domain [3,5-
7,9,11,12,19–26]. Between these two prediction programs, six of theTable 1
Prediction of the mutation effect.
Protein Exon Protein
[References]
PolyPhen-2 Signa
Most
Prediction Score Norm
DSP 2 p.Y6D [19] Probably damaging 0.996 Betw
p.A15V [20] Probably damaging 0.980
p.P17T [11] Probably damaging 0.996
p.P17S [3,9] Probably damaging 0.996
p.P17La Probably damaging 0.998
3 p.V18F [7,11,21,22] Probably damaging 0.991
p.V18D [5,12,23] Probably damaging 0.991
p.Q45Xb [22,24]
4 p.R68W [7,20] Probably damaging 1.000
a Our current study.
b The mutation creates a stop codon in exon 3 and cannot be analyzed by Poly Phen-2 pmutations (c.52-25del23bp, c.52-3C>G, c.52-3C>A, c.135+1G>A,
c.135+1G>T, c.135+3A>G) [3,6,7,11,25,26] were predicted to af-
fect splicing as the prediction value decreased sharply in both of the
Fruitﬂy Splice prediction and the SplicePort prediction (Table 2).
2.4. Summary of the studies of DSPP mutations
We found 50 independent families, from 21 different studies that
identiﬁed 36 mutations within DSPP for the hereditary dentin defects
including this study (Supplementary Fig. 1B) [3–7,9,11–13,15,19–28].
This allowed us to separately examine 36 mutations for DSP and DPP
in various ethnic families (Table 3). When all of the studies were
taken into account, we found that 15 missense or nonsense mutations
were located within the DSP domain [3,5–7,9,11,12,19–26], and 21
mutations located in the DPP domain cause frameshift mutations
[3,4,13,15,27,28]. Thus, we separately analyzed the studies for DSP
and DPP.
In protein DSP, the mutations were found in 15 Asian families, as
well as in nine European descent families. At the same time, the
frameshift mutations for DPP were found in nine Asian families and
in 17 European descent families. Therefore, the numbers of families
with DSPPmutations in different domains showed a signiﬁcant differ-
ence (X2=3.89, P=0.0486) or a trend of signiﬁcant difference (Fish-
er's exact test: Ptwo-sided=0.0882) between Asian families and
European descent families (Table 4).
In DSP and DPP coding region (exons), we found 87 Asian patients
and 29 European descent patients carrying the mutations in DSP do-
main. Moreover, 34 Asian patients and 43 European descent patients
have been identiﬁed to be affected by the mutations in DPP domain.
Then, the numbers of patients with the mutations in a different cod-
ing region showed a signiﬁcant difference (X2=18.82,
P=0.000014; Fisher's exact test: Ptwo-sided=0.000019) between the
Asian population and the European descent population (Table 5).
3. Discussion
In the present study, through linkage and sequencing analysis we
identiﬁed a novel functional C>T transition mutation (c.50C>T,
p.P17L, g.50C>T) in the DSPP gene in a Chinese family suffering
from DGI-II. A lowmaximal-LOD-score of 1.17 (theta=0.0) for mark-
er D4S2929 and D4S1563 was obtained in the linkage analysis. The
low LOD score was likely a result of modest family size and low poly-
morphic information content (PIC) of the STRmarkers (Supplementa-
ry Table 1). Fortunately, DNA sequence analysis of a known gene
responsible for DGI-II in this region, DSPP, enabled us to identify a
novel functional C>T transition mutation (c.50C>T, p.P17L,
g.50C>T). The p.P17L mutation resulted in a substitution of a prolinelP 3.0
likely cleavage site Max cleavage site probability
al Mutation Normal Mutation
een pos.15 and 16 Between pos.15 and 16 0.946 0.750
Between pos.21 and 22 0.550
Between pos.15 and 16 0.764
Between pos.15 and 16 0.764
Between pos.15 and 16 0.695
Between pos.15 and 16 0.923
Between pos.15 and 16 0.947
Between pos.15 and 16 0.947
Between pos.15 and 16 0.946
rediction program.
Table 2
Splice site prediction of the mutations in DSP protein.
Name Position Protein cDNA
[References]
Fruitﬂy splice SplicePort
Donor Acceptor Donor Acceptor
Normal Mutation Normal Mutation Normal Mutation Normal Mutation
DSP Exon2 p.Y6D c.16T>G [19] 0.98 0.98 0.904 1.084
p.A15V c.44C>T [20] 0.98 0.98 0.904 0.670
p.P17T c.49C>A [11] 0.98 0.98 0.904 0.872
p.P17S c.49C>T [3,9] 0.98 0.98 0.904 0.806
p.P17L c.50C>Ta 0.98 0.98 0.904 0.775
Intron2 c.52-25del23bp [6] 0.97 0 0.906 0
c.52-3C>G [25] 0.97 0 0.906 0
c.52-3C>A [7] 0.97 0.60 0.906 0
Exon3 p.V18F c.52G>T [7,11,21,22] 0.97 0.85 0.906 0
p.V18D c.53T>A [5,12,23] 0.97 0.91 0.906 0.482
p.Q45X c.133C>T [22,24] 0.89 0 0.939 0.387
Intron3 c.135+1G>A [11] 0.89 0 0.939 0
c.135+1G>T [3] 0.89 0 0.939 0
c.135+3A>G [26] 0.89 0 0.939 0
Exon4 p.R68W c.202A>T [7,20] 0.99 0.99 2.125 2.248
a Our current study.
Table 3
Summary of mutations in DSPP.
Position Coding region cDNA Protein Ethnicity a Phenotype References
Exon 2 DSP c.16T>G p.Y6D German DD-II Rajpar et al. 2002 [19]
DSP c.44C>T p.A15V American DGI-II Malmgren et al. 2004 [20]
DSP c.49C>A p.P17T Chinese DGI-II Xiao et al. 2001 [11]
DSP c.49C>T p.P17S Chinese DGI-II Zhang et al. 2007 [9];
Caucasian Mcknight et al. 2008a [3]
DSP c.50C>T p.P17L Chinese DGI-II Current study
Intron 2 c.52-25del23bp (IVS2-3C>A) Chinese DGI-II Wang et al. 2009 [6]
c.52-3C>G Korean DGI-II Kim et al. 2004 [25]
c.52-3C>A Finnish DGI-II Holappa et al. 2006 [7]
Exon 3 DSP c.52G>T p.V18F Chinese DGI-II/III Xiao et al. 2001 [11];
Korean Kim et al. 2005 [21];
Caucasian Kim et al. 2005 [21];
Chinese Song et al. 2006 [22];
Finnish Holappa et al. 2006 [7]
DSP c.53T>A p.V18D Korean DGI-II/III Lee et al. 2009 [12];
Japanese Kida et al. 2009 [5];
Korean Lee et al. 2011a [23]
DSP c.133C>T p.V18_Q45del (p.Q45X) Chinese DGI-II Zhang et al. 2001 [24];
Chinese Song et al. 2006 [22]
Intron 3 c.135+1G>A Chinese DGI-II Xiao et al. 2001 [11]
c.135+1G>T Caucasian DGI-II/III Mcknight et al. 2008a [3]
c.135+3A>G (IVS3+3A>G) Chinese DGI-II Bai et al. 2010 [26]
Exon 4 DSP c.202A>T p.R68W American DGI-II Malmgren et al. 2004 [20];
Finnish Holappa et al. 2006 [7]
Exon 5 DPP c.1686delT p.D562EfsX752 Finnish DD-II Nieminen et al. 2011 [13]
c.1830delC p.S610RfsX704 French DD-II Nieminen et al. 2011 [13]
c.1870-1873delTCAG p.S624TfsX687 Caucasian DD-II Mcknight et al. 2008a [3]
c.1918-1921delTCAG p.S640TfsX671 Caucasian DD-II Mcknight et al. 2008a [3];
Greek*3 Nieminen et al. 2011 [13]
c.1922-1925delACAG p.D641AfsX672 Finnish DD-II Nieminen et al. 2011 [13]
c.2040delC p.S680fsX1313 Chinese DD-II Song et al. 2008 [28]
c.2063delA p.D688VfsX626 Finnish*2 DD-II Nieminen et al. 2011 [13]
c.2272delA p.S758AfsX554 Caucasian DGI-II/III Mcknight et al. 2008a [3]
c.2349delT p.S783RfsX531 Spanish DGI-II Nieminen et al. 2011 [13]
c.2525delG p.S842TfsX471 Caucasian DGI-II/III Mcknight et al. 2008a [3]
c.2593delA p.S865fsX1313 Chinese DGI-II Song et al. 2008 [28]
c.2666delG p.S889TfsX425 Greek DGI-II Nieminen et al. 2011 [13]
c.2684delG p.S895fsX1313 Chinese DGI-II Song et al. 2008 [28]
c.2688delT Korean*2 DGI-II Lee et al. 2011b [15]
c.3141delC Caucasian DD Mcknight et al. 2008b [27]
c.3438delC p.D1146fsX1313 Chinese DGI-II Song et al. 2008 [28]
c.3546-3550delTAGCAinsG p.D1182fsX1312 Chinese DGI-II Song et al. 2008 [28]
c.3560delG Korean DGI-II Lee et al. 2011b [15]
c.3582-3591del10bp p.D1194EfsX117 Finnish DGI-II Nieminen et al. 2011 [13]
c.3599-3634del36bp and c.3715-3716ins18bp Del1160-1171 and Ins1198-1199 American DGI-III Dong et al. 2005 [4]
c.3625-3700del76bp p.D1209AfsX80 Vietnamese DGI-II Nieminen et al. 2011 [13]
a *2: the same mutation was identiﬁed in 2 different families. *3: the same mutation was identiﬁed in 3 different families.
223D. Li et al. / Genomics 99 (2012) 220–226
Table 4
DSPP mutations analysis in Asian and European descent families.
Protein Mutations Family Ethnicity X2 P-
value a
Fisher's exact test
Number Category Asian family European family P-value a (two sided)
DSP 15 Missense or nonsense 24 15 9 3.89 0.0486 0.0882
DPP 21 Frameshift 26 9 17
Total 36 50 24 26
a Signiﬁcant P value (b0.05) are in boldface.
224 D. Li et al. / Genomics 99 (2012) 220–226at position 17 with a leucine residue that co-segregated only in affect-
ed individuals. This mutation was not present in any unaffected fam-
ily members or in an additional 160 healthy control individuals.
Moreover, the genomic sequence that corresponds to the P17 residue
is evolutionarily conserved in humans and several other mammalian
species. A reasonable conclusion for these ﬁndings is that the p.P17L
mutation of DSPP caused DGI-II in the studied family.
To date, this is the third disease-causing mutation affecting the
DSPP P17 residue. Considering the evolutional conservation of the
P17 residue, and together with the ﬁndings from previous studies,
our results suggest that the P17 residue is a mutational hot-spot
that is critical to the function of DSPP [9,11]. Consistent with this con-
clusion, the PolyPhen-2 prediction for this alteration suggested Prob-
ably Damaging (Table 1).
This mutation (c.50C>T, p.P17L, g.50C>T) was located at the sec-
ond nucleotide position of the last codon within exon 2, and adjacent
to the signal peptide site, suggesting that it may interfere with signal
peptide cleavage [3,9,11]. A dominant negative effect caused by the
p.P17L might be responsible because this substitution could result
in defective signal peptide cleavage and/or protein secretion [23].
This hypothesis is supported by the results from our bioinformatic
analysis. When we used SignalP 3.0 prediction program to predict
the most likely cleavage site and the max cleavage site probability
of the signal peptide [29], the max cleavage site probability decreased
quickly from 0.946 to 0.695 between A15 and I16 for this mutation
(p.P17L) (Table 1), indicating that the mutation may affect signal
peptide cleavage.
Given the proximity to the border of exon 2/intron 2, the mutation
was also suspected to affect normal pre-mRNA splicing [12]. Howev-
er, bioinformatic analysis did not support the role of this mutation as
affecting splicing. There was no change in the prediction conﬁdence
value (0.98→0.98) using the Fruitﬂy Splice prediction program, and
only a small change in the splice donor site prediction value
(0.904→0.775) using the SplicePort prediction program (Table 2)
[30,31].
Previous studies reported mutations of the P17 that resulted in a
change of amino acid from a proline to either a serine (c.49C>T,
p.P17S) or a threonine (c.49C>A, p.P17T) [3,9,11]. Interestingly, pro-
line is a non-polar amino acid, and both serine and threonine are
polar amino acids. However, leucine is also a non-polar amino acid.
Therefore, our study would not support that the chemical character
of a polar or non-polar residue may play an important role in the mu-
tation of P17 for the function of DSPP. Furthermore, as proline is very
common in the beta-turn of protein secondary structure, and P17Table 5
DSPP mutations analysis in Asian and European descent patients.
Protein Exonic
mutations
Ethnicity
Asian patients European pati
DSP 9 87 29
DPP 21 34 43
Total 121 72
a Signiﬁcant P value (b0.05) are in boldface.residue is the second amino acid residue in the mature DSP protein,
this mutation (p.P17L) may directly affect the biological function of
DSP by changing its normal space conformation [9,32].
Unfortunately, little is currently known about the molecular
mechanisms by which DSPPmutations cause DGI-II and the above hy-
potheses remain to be investigated by functional studies.
To further investigate the nature of previously reported mutations
of DSPP, we performed additional analyses utilizing the results from
other studies and found 50 independent families from 21 different
studies (including this study) that identiﬁed 36 mutations within
DSPP [3–7,9,11–13,15,19–28] (Table 3). When all of the studies
were taken into account (including the ﬁndings of this study), we
found that 15 missense or nonsense mutations were located within
the DSP domain (9-exonic and 6-intronic mutations)
[3,5–7,9,11,12,19–26], and 21 frameshift mutations were located in
the DPP domain [3,4,13,15,27,28]. Bioinformatic analyses were una-
vailable for the frameshift mutations within the DPP domain, there-
fore we focused our analyses on the missense mutations.
A total of nine of the 15 missense mutations were predicted by the
PolyPhen-2 program to affect the structure or function of DSP. For
eight of the mutations, no predicting results outside of the Probably
Damaging were found (Table 1), consistent with the studies identify-
ing these mutations [3,5,7,9,11,12,19–24].
A total of ﬁve (p.Y6D, p.A15V, p.P17T, p.P17S, p.P17L) of the 9-
exonic mutations were predicted by the SignalP 3.0 program to affect
signal peptide processing, and that four of the mutations (p.V18F,
p.V18D, p.Q45X, p.R68W) may not inﬂuence the signal peptide cleav-
age (Table 1). These ﬁndings are consistent with the experimental re-
sults from several other studies [3,12,19,23].
In the analysis of the mutations on the pre-mRNA splicing, a total
of 15 mutations were identiﬁed within DSP, and six (c.52-25del23bp,
c.52-3C>G, c.52-3C>A, c.135+1G>A, c.135+1G>T, c.135+3A>G)
were found to affect splicing as the prediction value decreased sharp-
ly in both of the prediction programs (Table 2). Thus, these six muta-
tions may directly disrupt normal pre-mRNA splicing.
Interestingly, in our summary of the studies of DSPP mutations,
the numbers of the families with DSPPmutations in different domains
showed a signiﬁcant difference (P=0.0486) or a trend of signiﬁcant
difference (Fisher's exact test: Ptwo-sided=0.0882) between DSP and
DPP (Table 4). Furthermore, between the Asian and European descent
population, the numbers of patients carrying the mutations in a dif-
ferent coding region also showed a signiﬁcant difference
(P=0.000014; Fisher's exact test: Ptwo-sided=0.000019) (Table 5).
However, considering the modest sample size of the currentX2 P-value a Fisher's exact test
ents P-value a (two sided)
18.82 0.000014 0.000019
225D. Li et al. / Genomics 99 (2012) 220–226summary, the results were not robust enough to determine ethnicity-
speciﬁc genetic effects. As new studies emerge, the present ﬁndings
can be updated, and more reliable estimates of this difference in
both ethnic groups may be obtained.
In summary, the present study identiﬁed a novel, functional C>T
transition mutation, which is located within exon 2 of DSPP gene
that causes DGI-II in a Chinese family, and expands the spectrum of
mutations for DGI-II. Further research is needed to clarify the hypoth-
eses from the results of our bioinformatic analyses, and to relate this
to the molecular mechanisms by which DSPP mutations cause hered-
itary dentin defects.
4. Materials and methods
4.1. Enrolment of human subjects
The study was reviewed and approved by the genetic research
ethics committees of Xi'an Jiaotong University School of Medicine.
Written informed consent was obtained from all participants.
4.2. Subjects
The four-generation Chinese family with DGI-II consisted of 12 liv-
ing family members, of which ﬁve were affected (Fig. 1). Affected and
unaffected individuals from this family passed a physical exam and
were clinically diagnosed with DGI-II. Clinical and radiographic im-
ages were obtained (Fig. 2). No family-speciﬁc phenotypes or sex-
correlated characteristics were observed in the family.
4.3. Linkage and haplotype analysis
Human genomic DNA was isolated from whole blood using the
DNA Isolation Kit for Mammalian Blood (Tiangen Biotech Co., Ltd).
We genotyped ﬁve polymorphic microsatellite markers that ﬂanked
DSPP on chromosome 4 (D4S2409, D4S2622, D4S1542, D4S2929 and
D4S1563, spanning 2.6 Mb). Microsatellite markers were ampliﬁed
by PCR using ﬂuorescently labeled primers. Products were analyzed
by automated capillary genotyping on MegaBACE 1000 (Amersham
Pharmacia Biotech). A two-point linkage analysis was performed
using the software program LINKAGE 5.2 with the following genetic
model assumptions: autosomal dominance, disease-allele frequency
of 0.00001, evenly shared allele frequency, zero phenocopy rate, no
sex difference, and 100% penetrance [33–35]. Haplotypes were recon-
structed on the software program CYRILLIC, version 2.1.
4.4. Mutation analysis
Mutation screening was performed using direct DNA sequence
analysis. All ﬁve DSPP exons were ampliﬁed by using primers that
ﬂanked the exon–intron boundaries (Supplementary Table 2). Por-
tions of exon 4 were ampliﬁed by two separate PCR reactions that
yielded products that covered the whole exon. Similarly, exon 5 cov-
erage was obtained by amplifying six separate PCR fragments. PCR
was performed in 25 μl of standard PCR buffer containing 1.5 mM
MgCl2, 0.2 mM of each dNTP, 0.5 μl of each primer, 1 Unit of Taq
DNA polymerase, and 25 ng of human genomic DNA. The PCR thermal
cycle program was as follows: one cycle of 2 min for denaturation at
95 °C, 35 cycles of 30 s at 95 °C, 35 s at 55–64 °C depending on the
primers (Supplementary Table 2), 45 s at 72 °C, and one 7 min exten-
sion step at 72 °C. PCR products were analyzed using 1.5% agarose gel
electrophoresis. Puriﬁed PCR products were sequenced bidirectional-
ly using PCR primers as sequencing primers and the Applied Biosys-
tems Prism BigDye terminator cycle sequencing reaction kit. The
products were evaluated on an Applied Biosystems 3100 Genetic
Analyzer.4.5. Bioinformatic analysis of the mutation effect (including previous
reported mutations)
To investigate whether or how the mutations may affect the func-
tion of DSPP, we used various bioinformatics software programs. To
predict the impact of substitution of amino acid residues on protein
structure and function, we used the PolyPhen-2 program (http://
genetics.bwh.harvard.edu/pph2/) [36]. To predict the location of po-
tential cleavage sites, we used SignalP 3.0 (http://www.cbs.dtu.dk/
services/SignalP/) [29]. To predict effects on pre-mRNA splicing, we
used the Fruitﬂy Splice program (http://www.fruitﬂy.org) [31] and
SplicePort program (http://spliceport.cs.umd.edu) [30].4.6. Summary of the studies of DSPP mutations
The studies included in our summary were identiﬁed using Med-
line with the search terms “DSPP” and “Mutation”. All of the data an-
alyzed had been previously published. To assess potential genetic
differences in different ethnicity, Chi-squares, P value and Fisher's
exact test for comparison between the Asian population and the Eu-
ropean descent population were calculated using the SPSS 13.0
software.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ygeno.2012.01.006.Acknowledgments
We are indebted to all individuals who have participated in, or
helped with, our research. This study was supported by funding
from the Fundamental Research Funds for the Central Universities,
the Guanghua Innovation Experiment Project for Graduate Students
of Xi'an Jiaotong University (no. CX1106), the Ministry of Education,
PRC (no. 20090201120062), and the National Natural Science Foun-
dation of China (nos. 30900432 and 30800618).References
[1] J.W. Kim, J.P. Simmer, Hereditary dentin defects, J. Dent. Res. 86 (2007) 392–399.
[2] J.C. Hu, J.P. Simmer, Developmental biology and genetics of dental malformations,
Orthod. Craniofac. Res. 10 (2007) 45–52.
[3] D.A. McKnight, et al., A comprehensive analysis of normal variation and disease-
causing mutations in the human DSPP gene, Hum. Mutat. 29 (2008) 1392–1404.
[4] J. Dong, T. Gu, L. Jeffords, M. MacDougall, Dentin phosphoprotein compound mu-
tation in dentin sialophosphoprotein causes dentinogenesis imperfecta type III,
Am. J. Med. Genet. A 132A (2005) 305–309.
[5] M. Kida, T. Tsutsumi, M. Shindoh, H. Ikeda, T. Ariga, De novo mutation in the DSPP
gene associated with dentinogenesis imperfecta type II in a Japanese family, Eur.
J. Oral Sci. 117 (2009) 691–694.
[6] H. Wang, et al., A novel splice site mutation in the dentin sialophosphoprotein
gene in a Chinese family with dentinogenesis imperfecta type II, Mutat. Res.
662 (2009) 22–27.
[7] H. Holappa, P. Nieminen, L. Tolva, P.L. Lukinmaa, S. Alaluusua, Splicing site muta-
tions in dentin sialophosphoprotein causing dentinogenesis imperfecta type II,
Eur. J. Oral Sci. 114 (2006) 381–384.
[8] M. MacDougall, J. Dong, A.C. Acevedo, Molecular basis of human dentin diseases,
Am. J. Med. Genet. A 140 (2006) 2536–2546.
[9] X. Zhang, et al., A novel DSPP mutation is associated with type II dentinogenesis
imperfecta in a Chinese family, BMC Med. Genet. 8 (2007) 52.
[10] M.J. Barron, S.T. McDonnell, I. Mackie, M.J. Dixon, Hereditary dentine disorders:
dentinogenesis imperfecta and dentine dysplasia, Orphanet J. Rare Dis. 3 (2008)
31.
[11] S. Xiao, et al., Dentinogenesis imperfecta 1 with or without progressive hearing
loss is associated with distinct mutations in DSPP, Nat. Genet. 27 (2001) 201–204.
[12] S.K. Lee, et al., A novel mutation in the DSPP gene associated with dentinogenesis
imperfecta type II, J. Dent. Res. 88 (2009) 51–55.
[13] P. Nieminen, et al., Frameshift mutations in dentin phosphoprotein and depen-
dence of dentin disease phenotype on mutation location, J. Bone Miner. Res. 26
(2011) 873–880.
[14] Z. von Marschall, L.W. Fisher, Dentin sialophosphoprotein (DSPP) is cleaved into
its two natural dentin matrix products by three isoforms of bone morphogenetic
protein-1 (BMP1), Matrix Biol. 29 (2010) 295–303.
[15] K.E. Lee, et al., Novel dentin phosphoprotein frameshift mutations in dentinogen-
esis imperfecta type II, Clin. Genet. 79 (2011) 378–384.
226 D. Li et al. / Genomics 99 (2012) 220–226[16] S. Chen, et al., Bone morphogenetic protein 2 mediates dentin sialophosphopro-
tein expression and odontoblast differentiation via NF-Y signaling, J. Biol. Chem.
283 (2008) 19359–19370.
[17] Y. Yamakoshi, J.C. Hu, M. Fukae, H. Zhang, J.P. Simmer, Dentin glycoprotein: the
protein in the middle of the dentin sialophosphoprotein chimera, J. Biol. Chem.
280 (2005) 17472–17479.
[18] M. Prasad, W.T. Butler, C. Qin, Dentin sialophosphoprotein in biomineralization,
Connect. Tissue Res. 51 (2010) 404–417.
[19] M.H. Rajpar, M.J. Koch, R.M. Davies, K.T. Mellody, C.M. Kielty, M.J. Dixon, Mutation
of the signal peptide region of the bicistronic gene DSPP affects translocation to
the endoplasmic reticulum and results in defective dentine biomineralization,
Hum. Mol. Genet. 11 (2002) 2559–2565.
[20] B. Malmgren, S. Lindskog, A. Elgadi, S. Norgren, Clinical, histopathologic, and ge-
netic investigation in two large families with dentinogenesis imperfecta type II,
Hum. Genet. 114 (2004) 491–498.
[21] J.W. Kim, et al., Mutational hot spot in the DSPP gene causing dentinogenesis
imperfecta type II, Hum. Genet. 116 (2005) 186–191.
[22] Y. Song, et al., Phenotypes and genotypes in 2 DGI families with different DSPP
mutations, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102 (2006)
360–374.
[23] S.K. Lee, et al., Identiﬁcation of the DSPP mutation in a new kindred and pheno-
type–genotype correlation, Oral Dis. 17 (2011) 314–319.
[24] X. Zhang, et al., DSPP mutation in dentinogenesis imperfecta Shields type II, Nat.
Genet. 27 (2001) 151–152.
[25] J.W. Kim, et al., A novel splice acceptor mutation in the DSPP gene causing denti-
nogenesis imperfecta type II, Hum. Genet. 115 (2004) 248–254.[26] H. Bai, et al., A novel DSPP mutation causes dentinogenesis imperfecta type II in a
large Mongolian family, BMC Med. Genet. 11 (2010) 23.
[27] D.A. McKnight, J.P. Simmer, P.S. Hart, T.C. Hart, L.W. Fisher, Overlapping DSPP mu-
tations cause dentin dysplasia and dentinogenesis imperfecta, J. Dent. Res. 87
(2008) 1108–1111.
[28] Y.L. Song, C.N. Wang, M.W. Fan, B. Su, Z. Bian, Dentin phosphoprotein frameshift
mutations in hereditary dentin disorders and their variation patterns in normal
human population, J. Med. Genet. 45 (2008) 457–464.
[29] O. Emanuelsson, S. Brunak, G. von Heijne, H. Nielsen, Locating proteins in the cell
using TargetP, SignalP and related tools, Nat. Protoc. 2 (2007) 953–971.
[30] R.I. Dogan, L. Getoor, W.J. Wilbur, S.M. Mount, SplicePort—an interactive splice-
site analysis tool, Nucleic Acids Res. 35 (2007) W285–W291.
[31] S.M. Hebsgaard, P.G. Korning, N. Tolstrup, J. Engelbrecht, P. Rouze, S. Brunak,
Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and
global sequence information, Nucleic Acids Res. 24 (1996) 3439–3452.
[32] H. Fu, G.R. Grimsley, A. Razvi, J.M. Scholtz, C.N. Pace, Increasing protein stability
by improving beta-turns, Proteins 77 (2009) 491–498.
[33] G.M. Lathrop, J.M. Lalouel, Easy calculations of LOD scores and genetic risks on
small computers, Am. J. Hum. Genet. 36 (1984) 460–465.
[34] G.M. Lathrop, J.M. Lalouel, C. Julier, J. Ott, Strategies for multilocus linkage analysis
in humans, Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 3443–3446.
[35] Q.H. Xing, et al., A gene locus responsible for dyschromatosis symmetrica hered-
itaria (DSH) maps to chromosome 6q24.2-q25.2, Am. J. Hum. Genet. 73 (2003)
377–382.
[36] S. Sunyaev, V. Ramensky, I. Koch, W. Lathe III, A.S. Kondrashov, P. Bork, Prediction
of deleterious human alleles, Hum. Mol. Genet. 10 (2001) 591–597.
